May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Peptide

Abaloparatide

Also known as

Tymlos · PTHrP analog · BA058 (development code talk) · abaloparatide 80 mcg

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Bone-building medicineAbaloparatide, sold as Tymlos, is a daily injectable PTHrP analog discussed for osteoporosis.
Different productsTymlos, Forteo and Evenity are different medicines. A research vial labeled PTHrP is not the finished Tymlos pen.
Notes

Abaloparatide, best known as Tymlos, is a daily bone-building medicine discussed for osteoporosis. Patients compare scan improvements, injection symptoms and life after the course. Some feel little beyond the injection; others describe brief heart pounding or more persistent problems. Feeling something does not show that bone has improved.

A signal for making bone. Abaloparatide is a synthetic version of part of parathyroid hormone-related protein, or PTHrP. It activates a bone-building signal. Tymlos is the prescription pen; teriparatide, sold as Forteo, is a different peptide. TYMLOS prescribing information, revised August 2026 (Official context · Accessed 2026-09-30)

Why the names get mixed up. Patient discussions compare Tymlos and Forteo for osteoporosis, daily injections and tolerability. Evenity is another medicine, and an unspecified research vial labeled PTHrP is not the finished Tymlos pen.

Source context — TYMLOS prescribing information, revised August 2026: Manufacturer label hosted by NLM; supporting formal context only. Rat risk is explicitly rat-derived. Cannot validate reduced amounts, unofficial vials or forum claims.

What people notice

Bone scansOne person reported better hip and spine scores after two years, despite no improvement at the midpoint. Their spine still had osteoporosis.
Daily experienceSome report little beyond the injection; others describe racing heart, headache, nausea or fatigue. Feeling an effect does not show bone improvement.
Notes

Stronger bones without another disabling fracture. Patients describe wanting to keep walking, exercising and living independently. The_Bodybuilder1 reported hips improving from a T-score of −2.5 to −1.3 and spine from −4.1 to −3 after two years. The spine still had osteoporosis; improvement did not mean fracture risk disappeared. Tymlos results (Personal report · Accessed 2026-09-30) · Tymlos patient experiences (Community discussion · Accessed 2026-09-30)

Immediate sensations and bone improvement use different clocks. Posters describe racing heart or headache after injections; others notice no systemic effects. The_Bodybuilder1's scan halfway through a two-year course showed no improvement, followed by improvement at completion. A short symptom-free start cannot establish an early bone response. Tymlos patient experiences (Community discussion · Accessed 2026-09-30) · Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30) · Tymlos results (Personal report · Accessed 2026-09-30)

Abaloparatide, best known as Tymlos, is a daily bone-building medicine discussed for osteoporosis. Patients compare scan improvements, injection symptoms and life after the course. Some feel little beyond the injection; others describe brief heart pounding or more persistent problems. Feeling something does not show that bone has improved.

Feeling fine does not rule out a blood change. Solsticesunrise reported no felt side effects but elevated blood calcium that remained high after stopping calcium supplements, then a medicine switch. Patients also describe sting, redness, nausea, fatigue and mood complaints. Tymlos patient experiences (Community discussion · Accessed 2026-09-30)

Source context — Tymlos results: One person's self-reported scan history. Same author as the regrets-thread updates; not independent corroboration.

Source context — Tymlos patient experiences: Self-reports with different health histories. No denominator, scan validation or causation established.

Source context — Has anyone regretted taking Tymlos and why?: Updates from one author count as one history. Current prices and insurance coverage not inferred from old accounts.

Doses people talk about

80 mcg once dailyThe Tymlos pen amount repeated in discussion is 80 mcg beneath the skin per injection and per day; it comes from the label.
40 mcg in one accountOne patient described reducing from 80 to 40 mcg with clinician involvement and considering 50 mcg. Another said their clinician rejected reduction; equivalent benefit is not established.
Other numbersA 100 mcg appearance-forum suggestion lacks route, frequency and an outcome. Forteo's 20 mcg is not a Tymlos dose.
Notes

80 mcg once daily is the prescription amount circulating in discussion. The tracker repeats 80 micrograms per injection and per day, beneath the skin with the Tymlos pen. This is label-origin information, not a separate community-tested vial dose. Abaloparatide (Tymlos) — Half-Life & Dosing (Community guide · Accessed 2026-09-30)

Lower amounts are reported, with disagreement. Mayo poster jmla described reducing from 80 to 40 mcg per injection after symptoms, with clinician involvement, and considering 50 mcg. Reddit's trjustice said their clinician rejected reduction. These accounts do not establish equivalent benefit or a validated pen-adjustment method. Dosage Adjustments On Tymlos Pen, page 5 (Personal report · Accessed 2026-09-30) · Cut your Tymlos or Forteo dose in half? (Community discussion · Accessed 2026-09-30)

100 mcg appears as unsupported appearance-forum advice. A Looksmax reply to a 17-year-old suggested this amount without route, frequency or a treatment outcome. It is not a documented daily regimen or evidence of suitability for adolescents. Forteo's 20 mcg also must not become a Tymlos dose. BIOMAXX AMA PT.5 (Community opinion · Accessed 2026-09-30)

Source context — Abaloparatide (Tymlos) — Half-Life & Dosing: Commercial compilation, not a personal log. Lists 80 mcg as approved while elsewhere saying no approved dose quoted; 1.7-hour value has no source-specific origin. Referenced research does not automatically support each table field.

Source context — Dosage Adjustments On Tymlos Pen, page 5: Quoted/repeated entry and follow-ups describe one person. Frequency is not restated in every entry; article gives per-injection amounts and does not infer an alternative daily regimen or translate clicks.

Source context — Cut your Tymlos or Forteo dose in half?: Individual reported clinician opinions are not medical guidance. The referenced jmla story was opened at its original Mayo location.

Source context — BIOMAXX AMA PT.5: Advice without a personal outcome, route or frequency. Multiple quoted repeats remain one claim. Purchase discussion excluded. Recommendation and safety assurance rejected.

Half-life, onset & duration

Felt onsetRacing heart or headache can be reported after injection; others feel no systemic effect. Bone changes are assessed over months, rather than by an immediate sensation.
Felt durationSeparate people described headache/palpitations for about 20 minutes and racing heart for 45 minutes. These do not establish a usual symptom or bone-benefit window.
Half-lifeAbout 1 hour is label information repeated in a patient forum. A tracker's separate 1.7-hour model is unexplained; neither number describes bone-benefit duration.
Notes

Immediate sensations and bone improvement use different clocks. Posters describe racing heart or headache after injections; others notice no systemic effects. The_Bodybuilder1's scan halfway through a two-year course showed no improvement, followed by improvement at completion. A short symptom-free start cannot establish an early bone response. Tymlos patient experiences (Community discussion · Accessed 2026-09-30) · Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30) · Tymlos results (Personal report · Accessed 2026-09-30)

20 minutes and 45 minutes belong to different people. Outrageous-Tie-9538 described headache and palpitations for about 20 minutes. Comfortable-Self-423 reported racing heart for 45 minutes. Cazzeo's early mild back pain lasted five minutes; a separate back-pain account said about 45 minutes. These are symptom histories, not one standard duration. Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30) · Tymlos patient experiences (Community discussion · Accessed 2026-09-30)

Bone gains have no dependable single-dose duration in these accounts. Discussion follows scans over months and asks what happens after stopping. A daily injection schedule, a two-year course and a pen's 30-day storage limit describe different things. Tymlos results (Personal report · Accessed 2026-09-30)

About 1 hour is label information repeated in a patient forum. Mayo commenter njx58 repeats the label value, rather than reporting a personal blood measurement. It describes circulating drug decline, not symptom or benefit duration. Tymlos side effects I've encountered, page 41 (Community discussion · Accessed 2026-09-30)

1.7 hours is a separate tracker model. BioHack Track uses this unexplained estimate for its decay curve. It is not a personal measurement or a value to average with the label. Abaloparatide (Tymlos) — Half-Life & Dosing (Community guide · Accessed 2026-09-30)

Source context — Tymlos patient experiences: Self-reports with different health histories. No denominator, scan validation or causation established.

Source context — Has anyone regretted taking Tymlos and why?: Updates from one author count as one history. Current prices and insurance coverage not inferred from old accounts.

Source context — Tymlos results: One person's self-reported scan history. Same author as the regrets-thread updates; not independent corroboration.

Source context — Tymlos side effects I've encountered, page 41: Patient forum hosted by a medical institution, not institutional advice. Half-life repetition matches separately checked label; no original measurement supplied.

Source context — Abaloparatide (Tymlos) — Half-Life & Dosing: Commercial compilation, not a personal log. Lists 80 mcg as approved while elsewhere saying no approved dose quoted; 1.7-hour value has no source-specific origin. Referenced research does not automatically support each table field.

Cycles people discuss

18–24 monthsPatient discussion describes one long prescribed course, including two-year accounts. Vacation breaks and repeat courses have no settled community calendar.
After the courseReclast, Fosamax and Prolia appear as follow-on medicines. One changing follow-up history does not establish a general stopping rule.
Notes

One long prescribed course: 18–24 months in patient discussion. Patient accounts include two years of use and shorter periods interrupted by coverage or calcium concerns. They do not establish a bodybuilding cycle or repeat calendar. Vacation breaks remain an argument, not a settled off-week pattern. Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30) · Tymlos patient experiences (Community discussion · Accessed 2026-09-30)

The follow-on medicine is part of the conversation. Reclast, Fosamax and Prolia appear in follow-on discussion. Insurance interrupted The_Bodybuilder1's attempted Evenity follow-up; a later clinician-reviewed update described no further medicine. One evolving account cannot establish a general stopping rule. Tymlos side effects I've encountered, page 41 (Community discussion · Accessed 2026-09-30) · Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30)

Source context — Has anyone regretted taking Tymlos and why?: Updates from one author count as one history. Current prices and insurance coverage not inferred from old accounts.

Source context — Tymlos patient experiences: Self-reports with different health histories. No denominator, scan validation or causation established.

Source context — Tymlos side effects I've encountered, page 41: Patient forum hosted by a medical institution, not institutional advice. Half-life repetition matches separately checked label; no original measurement supplied.

Stacks

Calcium, vitamin D and liftingThese appear alongside Tymlos in patient logs, so a scan change cannot be credited to one change alone.
Follow-on medicinesReclast, Fosamax and Prolia appear after the course. These are follow-on treatments rather than a documented simultaneous combination.
Notes

Calcium, vitamin D and lifting: These appear alongside Tymlos in patient histories and complicate credit for a scan change. [community]

Insurance and other changes shape the outcome. A Cigna account describes interruption after four months and switching to teriparatide; another reports Blue Cross denial. Patient logs combine calcium, vitamin D and lifting, and treat Tymlos and Forteo as alternatives. Those factors complicate credit for any scan change. Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30)

Subsequent treatment: Follow-on antiresorptive medicines are discussed after the bone-building course, rather than as a documented simultaneous stack. [community]

The follow-on medicine is part of the conversation. Reclast, Fosamax and Prolia appear in follow-on discussion. Insurance interrupted The_Bodybuilder1's attempted Evenity follow-up; a later clinician-reviewed update described no further medicine. One evolving account cannot establish a general stopping rule. Tymlos side effects I've encountered, page 41 (Community discussion · Accessed 2026-09-30) · Has anyone regretted taking Tymlos and why? (Community discussion · Accessed 2026-09-30)

Source context — Has anyone regretted taking Tymlos and why?: Updates from one author count as one history. Current prices and insurance coverage not inferred from old accounts.

Source context — Tymlos side effects I've encountered, page 41: Patient forum hosted by a medical institution, not institutional advice. Half-life repetition matches separately checked label; no original measurement supplied.

Watch for

Calcium and dizzinessOne user felt no side effects despite elevated blood calcium. Label cautions include dizziness on standing, high calcium, kidney stones and severe allergy.
Hair and sleep complaintsHair shedding is reported and disputed. Morning nausea improved with night use for one person, while bedtime use brought insomnia for another.
Long-term limitsLabel cautions include higher-risk bone conditions and growing bones; use beyond two years, pregnancy and nursing remain limited or unstudied in this record.
Notes

Feeling fine does not rule out a blood change. Solsticesunrise reported no felt side effects but elevated blood calcium that remained high after stopping calcium supplements, then a medicine switch. Patients also describe sting, redness, nausea, fatigue and mood complaints. Tymlos patient experiences (Community discussion · Accessed 2026-09-30)

Label warnings extend beyond brief symptoms. Dizziness on standing can occur within four hours. The label flags high calcium, kidney stones and severe allergy. It discourages lifetime use beyond two years and identifies higher-risk bone conditions, skeletal cancer or radiation, and growing bones. TYMLOS prescribing information, revised August 2026 (Official context · Accessed 2026-09-30)

Morning versus bedtime has opposing reports. Gato-afortunado said morning injections brought all-day low-level nausea that improved with night use. Trjustice reported insomnia after bedtime use and moved to morning. Neither establishes the best hour for everyone. Cut your Tymlos or Forteo dose in half? (Community discussion · Accessed 2026-09-30)

Hair shedding is reported and disputed. Sensitive-Sky6728 described continuing clumps and scalp discomfort; bluekmg described shedding that stopped with regrowth. Another six-month user reported none, and one user blamed something else for thinning. These reports preserve the concern without proving the drug caused it; the hair thread's copied AI explanation is not clinical evidence. I'm on Tymlos and losing clumps of hair (Personal report · Accessed 2026-09-30) · Tymlos vs Forteo (Community discussion · Accessed 2026-09-30)

Long-term and pregnancy uncertainty remain. Abaloparatide caused bone tumors in rats. Reassuring human observational evidence concerns teriparatide, not direct long-term abaloparatide tracking. Tymlos data beyond two years remain limited; pregnancy, nursing and specific drug-interaction data are absent. TYMLOS prescribing information, revised August 2026 (Official context · Accessed 2026-09-30) · FDA Forteo Supplement 54 multidisciplinary review — observational study population (Official context · Accessed 2026-09-30)

Source context — Tymlos patient experiences: Self-reports with different health histories. No denominator, scan validation or causation established.

Source context — TYMLOS prescribing information, revised August 2026: Manufacturer label hosted by NLM; supporting formal context only. Rat risk is explicitly rat-derived. Cannot validate reduced amounts, unofficial vials or forum claims.

Source context — Cut your Tymlos or Forteo dose in half?: Individual reported clinician opinions are not medical guidance. The referenced jmla story was opened at its original Mayo location.

Source context — I'm on Tymlos and losing clumps of hair: Patient experience does not establish causation. Prior fractures, other medicines and stress are possible confounders; updates are not new people.

Source context — Tymlos vs Forteo: Opinions and personal histories, not a trial review. Linked studies not inspected and no comparative efficacy conclusion adopted.

Source context — FDA Forteo Supplement 54 multidisciplinary review — observational study population: Primary regulatory review of teriparatide, not an abaloparatide cohort. Only relevant textual passage inspected, not all 210 pages.

Full notes

Abaloparatide, best known as Tymlos, is a daily bone-building medicine discussed for osteoporosis. Patients compare scan improvements, injection symptoms and life after the course. Some feel little beyond the injection; others describe brief heart pounding or more persistent problems. Feeling something does not show that bone has improved.

What Abaloparatide actually is

  • A signal for making bone. Abaloparatide is a synthetic version of part of parathyroid hormone-related protein, or PTHrP. It activates a bone-building signal. Tymlos is the prescription pen; teriparatide, sold as Forteo, is a different peptide. Official context
  • Why the names get mixed up. Patient discussions compare Tymlos and Forteo for osteoporosis, daily injections and tolerability. Evenity is another medicine, and an unspecified research vial labeled PTHrP is not the finished Tymlos pen. Community

Benefits people seek and report

  • Stronger bones without another disabling fracture. Patients describe wanting to keep walking, exercising and living independently. The_Bodybuilder1 reported hips improving from a T-score of −2.5 to −1.3 and spine from −4.1 to −3 after two years. The spine still had osteoporosis; improvement did not mean fracture risk disappeared. Personal report Reddit r/osteoporosis
  • An easier daily routine. One six-month user valued the opened pen's room-temperature storage for travel. Other posters call Tymlos stronger at the spine or easier to tolerate than Forteo, while a reply challenges the comparison evidence. These are discussion points, not a reliable ranking for an individual. Reddit r/osteoporosis

Doses people discuss

  • 80 mcg once daily is the prescription amount circulating in discussion. The tracker repeats 80 micrograms per injection and per day, beneath the skin with the Tymlos pen. This is label-origin information, not a separate community-tested vial dose. Community guide Community
  • Lower amounts are reported, with disagreement. Mayo poster jmla described reducing from 80 to 40 mcg per injection after symptoms, with clinician involvement, and considering 50 mcg. Reddit's trjustice said their clinician rejected reduction. These accounts do not establish equivalent benefit or a validated pen-adjustment method. Personal report Reddit r/osteoporosis
  • 100 mcg appears as unsupported appearance-forum advice. A Looksmax reply to a 17-year-old suggested this amount without route, frequency or a treatment outcome. It is not a documented daily regimen or evidence of suitability for adolescents. Forteo's 20 mcg also must not become a Tymlos dose. Looksmax.gg Community

Half-life: what the numbers mean

  • About 1 hour is label information repeated in a patient forum. Mayo commenter njx58 repeats the label value, rather than reporting a personal blood measurement. It describes circulating drug decline, not symptom or benefit duration. Mayo Clinic Connect user forum
  • 1.7 hours is a separate tracker model. BioHack Track uses this unexplained estimate for its decay curve. It is not a personal measurement or a value to average with the label. Community guide

Onset: when people notice something

  • Immediate sensations and bone improvement use different clocks. Posters describe racing heart or headache after injections; others notice no systemic effects. The_Bodybuilder1's scan halfway through a two-year course showed no improvement, followed by improvement at completion. A short symptom-free start cannot establish an early bone response. Reddit r/osteoporosis Reddit r/osteoporosis Personal report

Duration: how long an experience lasts

  • 20 minutes and 45 minutes belong to different people. Outrageous-Tie-9538 described headache and palpitations for about 20 minutes. Comfortable-Self-423 reported racing heart for 45 minutes. Cazzeo's early mild back pain lasted five minutes; a separate back-pain account said about 45 minutes. These are symptom histories, not one standard duration. Reddit r/osteoporosis Reddit r/osteoporosis Community
  • Bone gains have no dependable single-dose duration in these accounts. Discussion follows scans over months and asks what happens after stopping. A daily injection schedule, a two-year course and a pen's 30-day storage limit describe different things. Personal report Community

Cycles and what happens afterward

  • One long prescribed course: 18–24 months in patient discussion. Patient accounts include two years of use and shorter periods interrupted by coverage or calcium concerns. They do not establish a bodybuilding cycle or repeat calendar. Vacation breaks remain an argument, not a settled off-week pattern. Reddit r/osteoporosis Reddit r/osteoporosis Community
  • The follow-on medicine is part of the conversation. Reclast, Fosamax and Prolia appear in follow-on discussion. Insurance interrupted The_Bodybuilder1's attempted Evenity follow-up; a later clinician-reviewed update described no further medicine. One evolving account cannot establish a general stopping rule. Mayo Clinic Connect user forum Reddit r/osteoporosis Community

Cautions that matter

  • Feeling fine does not rule out a blood change. Solsticesunrise reported no felt side effects but elevated blood calcium that remained high after stopping calcium supplements, then a medicine switch. Patients also describe sting, redness, nausea, fatigue and mood complaints. Reddit r/osteoporosis Community
  • Label warnings extend beyond brief symptoms. Dizziness on standing can occur within four hours. The label flags high calcium, kidney stones and severe allergy. It discourages lifetime use beyond two years and identifies higher-risk bone conditions, skeletal cancer or radiation, and growing bones. Official context
  • Long-term and pregnancy uncertainty remain. Abaloparatide caused bone tumors in rats. Reassuring human observational evidence concerns teriparatide, not direct long-term abaloparatide tracking. Tymlos data beyond two years remain limited; pregnancy, nursing and specific drug-interaction data are absent. Official context Official context

What the discussions add

  • Morning versus bedtime has opposing reports. Gato-afortunado said morning injections brought all-day low-level nausea that improved with night use. Trjustice reported insomnia after bedtime use and moved to morning. Neither establishes the best hour for everyone. Reddit r/osteoporosis
  • Hair shedding is reported and disputed. Sensitive-Sky6728 described continuing clumps and scalp discomfort; bluekmg described shedding that stopped with regrowth. Another six-month user reported none, and one user blamed something else for thinning. These reports preserve the concern without proving the drug caused it; the hair thread's copied AI explanation is not clinical evidence. Personal report Reddit r/osteoporosis
  • Storage convenience still has limits. The opened pen makes travel easier in patient discussion, but heat remains a concern. Label storage is refrigeration before use, then 68–77 °F for up to 30 days, without freezing or excess heat. Reddit r/osteoporosis Community Official context
  • Insurance and other changes shape the outcome. A Cigna account describes interruption after four months and switching to teriparatide; another reports Blue Cross denial. Patient logs combine calcium, vitamin D and lifting, and treat Tymlos and Forteo as alternatives. Those factors complicate credit for any scan change. Reddit r/osteoporosis Community
  • Biohacking interest is not a treatment log. MESO-Rx includes a request for personal abaloparatide experience, with no outcome supplied. The appearance-forum safety assurance is unsupported. MESO-Rx Looksmax.gg

Open in the directory ↗All STUDresearch topics →